The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook

Go back to The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook

Chemours (CC) Misses Q4 EPS by 12c, Offers Guidance

February 10, 2022 4:31 PM EST

Chemours (NYSE: CC) reported Q4 EPS of $0.81, $0.12 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.57 million.

GUIDANCE:

Chemours sees FY2022 EPS of $4.07-$4.70, versus the consensus of $4.54.

For earnings history and earnings-related data on Chemours (CC) click here.

... More